Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores

BJU International

Volumn 88, Issue 7, 2001, Pages 722-726

  Grossklaus, D J ^a   Coffey, C S ^a   Shappell, S B ^a   Jack, G S ^a   Cookson, M S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Needle; Pathology; Prostate; Prostatectomy; Prostatic neoplasms; Radical

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; STATISTICAL MODEL; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 0035788612     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-4096.2001.02413.x     Document Type: Article

References (21)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-4
2. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsy. J Urol 1998; 159: 1247-50
3. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy strategy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000; 163: 163-6
4. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199
5. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of non palpable (stage T1C) prostate cancer. JAMA 1994; 271: 368-74
6. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Uro 2000; 163: 174-8
7. Wheeler TM. Anatomic considerations in carcinoma of the prostate. Urol Clin North Am 1989; 16: 623
8. Gleason DF, Melinger GT and Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostate carcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58
9. Stamey TA, McNeal JE, Freiha FS, Redwine EA. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235
10. Babaian RJ, Troncoso P, Steelhammer LC, Lloreta-Trull J, Ramirez EI. Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol 1995; 154: 1808-12
11. Cupp MR, Bostwick DG, Myers RP, Oesterling JE. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 1995; 153: 1543-8
12. Bostwick DG, Cupp MR, Oesterling JE. Tumor volume in prostate cancer: correlation of needle biopsy and radical prostatectomy findings. Mod Path 1993; 6: 70A
13. Gohji K, Nomi M, Kizaki T et al. An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer. Br J Urol 1997; 79: 602-7
14. Terris MK, Haney DJ, Johnstone IM, McNeal JE, Stamey TA. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 1994; 45: 75-80
15. Iczkowski KA, Bostwick DG. Prostate Biopsy 1999: Strategies and significance of pathologic findings. Sem Urol Oncol 1999; 17: 177-86
16. Humphrey PA, Baty J, Keetch D. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer 1995; 75: 1842-9
17. Cheng L, Slezak J, Bergstralh EJ et al. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Onc 2000; 18: 2862-8
18. Ogawa O, Egawa S, Arai Y, Tobisu K, Yoshida O, Kato T. Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer. Int J Urol 1998; 5: 454-8
19. Wills ML, Sauvageot J, Partin AW, Gurganus R, Epstein JI. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1998; 51: 759-64
20. Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA. Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer 1995; 75: 530-8
21. Goto Y, Ohori M, Scardino PT. Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol 1998; 5: 337-42